Dr. Martens (DOCS)

Sector:

Personal Goods

Index:

FTSE 250

50.25p
   
  • Change Today:
    -1.15p
  • 52 Week High: 95.95
  • 52 Week Low: 47.52
  • Currency: UK Pounds
  • Shares Issued: 964.54m
  • Volume: 1,108,120
  • Market Cap: £484.68m
  • Beta: 0.01

Dr. Martens Overview

Dr. Martens operates in the global footwear market. Statista estimates that global retail sales of footwear in 2019 were £341 billion representing 12 billion pairs of footwear. Dr. Martens has a diversified global presence, with sales in more than 60 countries. The Group’s current geographical footprint, in terms of total Group revenue, is more weighted towards the US and EMEA, with APAC representing 20% of Dr. Martens’ FY20 revenue as compared to 29% for retail sales of the entire footwear market.

Key Personnel

CEO: Kenny Wilson
CFO: Giles Wilson
Chairman: Paul Mason
Independent Non-Executive Director: Andrew Harrison
Independent Non-Executive Director: Robyn Perriss
Independent Non-Executive Director: Ian Rogers
Senior Independent Non-Executive Director: Lynne Weedall
Non-Executive Dir: Benoit Vauchy, Tara Alhadef, Robert Hanson 

Contact Details

Address: 28 Jamestown Road, Camden, London, United Kingdom, NW1 7BY
Website: http://www.drmartensplc.com

Listings

Sector: Personal Goods(LSE)
Index: FTSE 250, FTSE 350, FTSE All-Share
ISIN: GB00BL6NGV24

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Dr. Martens Market Data

Currency UK Pounds
Share Price 50.25p
Change Today -1.15p
% Change -2.24 %
52 Week High 95.95
52 Week Low 47.52
Volume 1,108,120
Shares Issued 964.54m
Market Cap £484.68m
Beta 0.01

Dr. Martens Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
57.16% above the market average57.16% above the market average57.16% above the market average57.16% above the market average57.16% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average
Price Trend
54.13% below the market average54.13% below the market average54.13% below the market average54.13% below the market average54.13% below the market average
60% below the sector average60% below the sector average60% below the sector average60% below the sector average60% below the sector average
Income
56.46% above the market average56.46% above the market average56.46% above the market average56.46% above the market average56.46% above the market average
Sector averageSector averageSector averageSector averageSector average
Growth
89.79% below the market average89.79% below the market average89.79% below the market average89.79% below the market average89.79% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Dr. Martens Dividends

  Latest Previous
  Interim Final
Ex-Div 06-Mar-25 29-Aug-24
Paid 08-Apr-25 01-Oct-24
Amount 0.85p 0.99p

Trades for 11-Apr-2025

Time Volume / Share Price
15:56 1,043 @ 50.20p
15:56 1,097 @ 50.25p
15:56 106 @ 50.25p
15:56 1,203 @ 50.35p
15:56 1,986 @ 50.30p

Dr. Martens Key Personnel

Chair Paul Mason
CEO Kenny Wilson
CFO Giles Wilson

Top of Page